EMPOWER TeleECHO - Apr. 2021 (LIVE)
Ended May 25, 2021
Full course description
At the conclusion of this activity, learners will be able to:
- Evaluate best evidence-based practices needed to effectively manage those with opioid and/or substance use disorder
- Discuss clinical practice guidelines, innovations and tools needed to manage and approach opioid and/or substance use disorder cases
- Recognize facilitators and barriers to managing patients at risk for or suffering from opioid use disorder
Texas A&M University College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
DESIGNATIONTexas A&M University College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.
This course has been designated by the Texas A&M University College of Medicine for 1.0 hour of education in education in pain management and the prescription of opioids; medical ethics and/or professional responsibility.
Hector Chapa, MD, faculty for this activity, has no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, re-selling, or distributing healthcare products used by or on patients.
PLANNERS DISCLOSURESThe planners have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, re-selling, or distributing healthcare products used by or on patients.
This CME activity is supported by an educational grant from "Amerigroup Texas, a division of Anthem, Inc."